Xcenda Presents Co-Authored Posters at The 14th International Symposium on Myelodysplastic Syndromes

Xcenda is proud to co-present recent research and findings at The 14th International Symposium on Myelodysplastic Syndromes

Valencia, Spain - May 3-6, 2017

Abstract#: MDS17-0063

Survival Outcomes After First-line Therapy in Higher-risk Myelodysplastic Syndromes (HR-MDS) Using a United States (US) Electronic Medical Record (EMR)-based Cohort